Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure (ANTHEM-HF) Study

NCT01823887 is registered in ClinicalTrials.gov with Cyberonics, Inc. as lead sponsor.

NCT NCT01823887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01823887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure (ANTHEM-HF) Study
Lead sponsor
Cyberonics, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2012
Completion date
June 30, 2014
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure